[1] ETTER M C, PANUNTO T W.1, 3-Bis(m-nitrophenyl)urea: an exceptionally good complexing agent for proton acceptors[J]. Journal of the American Chemical Society, 1988, 110(17): 5896-5897. [2] CUSTELCEAN R.Crystal engineering with urea and thiourea hydrogen-bonding groups[J]. Chemical Communications, 2008(3): 295-307. [3] ETTER M C, URBANCZYK-LIPKOWSKA Z, ZIA-EBRAHIMI M, et al.Hydrogen bond-directed cocrystallization and molecular recognition properties of diarylureas[J]. Journal of the American Chemical Society, 1990, 112(23): 8415-8426. [4] JAGTAP A D, KONDEKAR N B, SADANI A A, et al.Ureas: applications in drug design[J]. Current Medicinal Chemistry, 2017, 24(6): 622-651. [5] GALLOU I.Unsymmetrical ureas. synthetic methodologies and application in drug design[J]. Organic Preparations and Procedures International, 2007, 39(4): 355-383. [6] KATSILAMBROS N, DIAKOUMOPOULOU E, IOANNIDIS I, et al.Diabetes in clinical practice[M]. Chichester, UK: John Wiley & Sons, Ltd, 2006. [7] LODÉN M. Urea-containing moisturizers influence barrier properties of normal skin[J]. Archives of Dermatological Research, 1996, 288(2): 103-107. [8] REGAN J, BREITFELDER S, CIRILLO P, et al.Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate[J]. Journal of Medicinal Chemistry, 2002, 45(14): 2994-3008. [9] WANG H, HUANG B, WANG W, et al.High urea induces depression and LTP impairment through mTOR signalling suppression caused by carbamylation[J]. EBioMedicine, 2019, 48: 478-490. [10] GARUTI L, ROBERTI M, BOTTEGONI G, et al.Diaryl urea: a privileged structure in anticancer agents[J]. Current Medicinal Chemistry, 2016, 23(15): 1528-1548. [11] KANDEKAR S, PREET R, KASHYAP M, et al.Structural elaboration of a natural product: identification of 3, 3'-diindolylmethane aminophosphonate and urea derivatives as potent anticancer agents[J]. Chem Med Chem, 2013, 8(11): 1873-1884. [12] SONG D Q, DU N N, WANG Y M, et al.Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents[J]. Bioorganic & Medicinal Chemistry, 2009, 17(11): 3873-3878. [13] LI H Q, LV P C, YAN T, et al.Urea derivatives as anticancer agents[J]. Anti-Cancer Agents in Medicinal Chemistry, 2009, 9(4): 471-480. [14] BORELLI C, BIELFELDT S, BORELLI S, et al.Cream or foam in pedal skin care: towards the ideal vehicle for urea used against dry skin[J]. International Journal of Cosmetic Science, 2011, 33(1): 37-43. [15] CIVALLERI B, ZICOVICH-WILSON C M, VALENZANO L, et al. B3LYP augmented with an empirical dispersion term (B3LYP-D*) as applied to molecular crystals[J]. Cryst Eng Comm, 2008, 10(4): 405-410. [16] TIRADO-RIVES J, JORGENSEN W L.Performance of B3LYP density functional methods for a large set of organic molecules[J]. Journal of Chemical Theory and Computation, 2008, 4(2): 297-306. [17] Sheldrick G M.SHELXL-2014/7: program for the solution of crystal structures[J].Göttingen: University of Göttingen, 2014. [18] Sheldrick G M.SHELXS-2014/7: program for the refinement of crystal structures[J].Göttingen: University of Göttingen, 2014. [19] 黎唯,谢惠定,黄燕,等.Gaussian09/GaussView5.0在分析化学教学中的应用[J].昆明医科大学学报,2016,37(10):134-136. LI W, XIE H D, HUANG Y, et al.Application of Gaussian 09/GaussView 5.0 in analytical chemistry teaching[J]. Journal of Kunming Medical University, 2016, 37(10): 134-136(in Chinese). [20] Deppmeier B J, Driessen A J, Hehre T S, et al.Spartan ‘08, V1.0.0[CP]. Irvine CA: Wavefunction Inc, 2009. |